MERS-CoV, Saudi Arabia: MoH reports one new case, fatal (October 31 2013): 125 cases so far

[Giuseppe]

[Source: Saudi Arabia Ministry of Health, full page in Arabic: (LINK). Automatic translation.]


MERS-CoV, Saudi Arabia: MoH reports one new case, fatal

(October 31 2013)


In the framework of the epidemiological investigation and ongoing follow-up carried out by the Ministry of Health for the novel Coronavirus that causes Middle East respiratory syndrome (MERS-CoV), the ministry announces the registration of the death of an infected case with the virus in the Eastern Province.

It is a citizen at the age of 56 years, mixing with confirmed cases, and they have several chronic diseases. ?God rest in peace.


-
------

[Giuseppe]

MERS-CoV, Saudi Arabia: MoH reports one new case, fatal (October 31 2013): 125 cases so far

[Source: World Health Organization, full page: (LINK). Edited.]


Middle East respiratory syndrome coronavirus (MERS-CoV) ? update

D.O.N. / 4 November 2013


WHO has been informed of an additional laboratory-confirmed case of infection with Middle East respiratory syndrome coronavirus (MERS-CoV) from Saudi Arabia.

The patient is a 56-year-old woman with underlying medical conditions from the Eastern Region. She became ill on 26 October 2013 and died on 30 October 2013. She had no contact with animals, but had contact with a previously laboratory confirmed case.

Globally, from September 2012 to date, WHO has been informed of a total of 150 laboratory-confirmed cases of infection with MERS-CoV, including 64 deaths.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns.

Health care providers are advised to maintain vigilance. Recent travellers returning from the Middle East who develop SARI should be tested for MERS-CoV as advised in the current surveillance recommendations.

Patients diagnosed and reported to date have had respiratory disease as their primary illness. Diarrhoea is commonly reported among the patients and severe complications include renal failure and acute respiratory distress syndrome (ARDS) with shock. It is possible that severely immunocompromised patients can present with atypical signs and symptoms.

Health care facilities are reminded of the importance of systematic implementation of infection prevention and control (IPC). Health care facilities that provide care for patients suspected or confirmed with MERS-CoV infection should take appropriate measures to decrease the risk of transmission of the virus to other patients, health care workers and visitors.

All Member States are reminded to promptly assess and notify WHO of any new case of infection with MERS-CoV, along with information about potential exposures that may have resulted in infection and a description of the clinical course. Investigation into the source of exposure should promptly be initiated to identify the mode of exposure, so that further transmission of the virus can be prevented.

WHO does not advise special screening at points of entry with regard to this event nor does it currently recommend the application of any travel or trade restrictions.

WHO has convened an Emergency Committee under the International Health Regulations (IHR) to advise the Director-General on the status of the current situation. The Emergency Committee, which comprises international experts from all WHO Regions, unanimously advised that, with the information now available, and using a risk-assessment approach, the conditions for a Public Health Emergency of International Concern (PHEIC) have not at present been met.


-
------